Welcome to our dedicated page for Walgreen Boots SEC filings (Ticker: WBA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Walgreens Boots Alliance, Inc. filings document the company's transition out of public-company reporting after its acquisition by Sycamore Partners. The record includes Form 25 delisting materials for WBA common stock and listed notes on Nasdaq and Form 15 certification covering termination of registration or suspension of Exchange Act reporting duties.
WBA's 8-K filings also disclose material events tied to the transaction period, including shareholder voting matters, temporary suspension of trading under employee benefit plans, material agreements, capital-structure matters and operating results. The filings identify covered securities such as common stock and multiple Walgreens Boots Alliance and Walgreen Co. senior notes.
Walgreens Boots Alliance (Nasdaq: WBA) filed its Q3 FY25 10-Q for the quarter ended May 31 2025. The filing confirms three operating segments—United States Retail Pharmacy, International and US Healthcare—and details the ongoing Footprint Optimization Program and Transformational Cost Management Program, which generated asset impairments, lease-related exit costs and severance charges across segments.
Liquidity updates include a new April 2025 Accounts Receivable Revolving Facility and disclosure of $3.6 bn notes due 2025 and $2.125 bn notes due 2026. The company also consolidates a variable-interest entity and notes subsequent-event activity related to its Cencora equity investment.
Management signals continued store rationalization and cost reduction to support US Healthcare growth while addressing near-term refinancing needs.
Walgreens Boots Alliance (Nasdaq: WBA) filed a Form 8-K under Item 2.02 to furnish its fiscal third-quarter 2025 results (quarter ended May 31 2025). A detailed press release is attached as Exhibit 99.1 and incorporated by reference; the body of the 8-K contains no financial tables. The information is "furnished," not "filed," avoiding Section 18 liability. No guidance revisions, strategic transactions or other material events were disclosed. The sole purpose is compliance with Regulation FD—making the earnings release simultaneously available to all investors. The report was signed by CFO Manmohan Mahajan on June 26 2025.